Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Net Margin (2021 - 2025)

HeartSciences filings provide 5 years of Net Margin readings, the most recent being 97269.0% for Q4 2025.

  • On a quarterly basis, Net Margin changed N/A to 97269.0% in Q4 2025 year-over-year; TTM through Jan 2026 was 98078.72%, a 5155990.0% decrease, with the full-year FY2025 number at 203517.79%, down 16771215.0% from a year prior.
  • Net Margin hit 97269.0% in Q4 2025 for HeartSciences, up from 108305.63% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 10048.78% in Q3 2021 to a low of 108305.63% in Q3 2025.
  • Median Net Margin over the past 5 years was 48741.44% (2022), compared with a mean of 53102.13%.
  • Biggest five-year swings in Net Margin: crashed -3912947bps in 2022 and later skyrocketed 5596161bps in 2024.
  • HeartSciences' Net Margin stood at 10048.78% in 2021, then crashed by -389bps to 49178.25% in 2022, then grew by 9bps to 44830.28% in 2023, then skyrocketed by 75bps to 11182.5% in 2024, then crashed by -770bps to 97269.0% in 2025.
  • The last three reported values for Net Margin were 97269.0% (Q4 2025), 108305.63% (Q3 2025), and 48304.62% (Q2 2025) per Business Quant data.